Qube Research & Technologies (QRT)’s Douglas Elliman DOUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,381
Closed -$51.9K 3662
2025
Q2
$51.9K Sell
22,381
-135,084
-86% -$289K ﹤0.01% 3143
2025
Q1
$271K Sell
157,465
-372,934
-70% -$675K ﹤0.01% 2767
2024
Q4
$886K Buy
530,399
+303,790
+134% +$584K ﹤0.01% 2225
2024
Q3
$415K Buy
226,609
+29,433
+15% +$50.5K ﹤0.01% 2334
2024
Q2
$229K Buy
197,176
+117,441
+147% +$148K ﹤0.01% 2391
2024
Q1
$126K Sell
79,735
-19,883
-20% -$40.7K ﹤0.01% 3217
2023
Q4
$294K Sell
99,618
-219,151
-69% -$459K ﹤0.01% 2591
2023
Q3
$720K Sell
318,769
-105,624
-25% -$243K ﹤0.01% 1871
2023
Q2
$942K Buy
+424,393
New +$1.17M ﹤0.01% 1331
2023
Q1
Sell
-43,129
Closed -$167K 2637
2022
Q4
$167K Buy
+43,129
New +$172K ﹤0.01% 1868
2022
Q2
Sell
-73,294
Closed -$510K 2627
2022
Q1
$510K Buy
73,294
+1,912
+3% +$14.5K ﹤0.01% 1520
2021
Q4
$782K Buy
+71,382
New +$803K 0.01% 1331

Other funds holding DOUG

Qube Research & Technologies (QRT)'s DOUG Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Douglas Elliman (DOUG) in Q3 2025, closing a stake of 22,381 shares — an estimated $51.9K sold.

Qube Research & Technologies (QRT) first reported a position in DOUG in Q4 2021 and held it in 12 quarters. The position peaked at $942K in Q2 2023. 128 funds tracked by Wall St. Rank hold DOUG as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Douglas Elliman position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 22,381 Douglas Elliman shares in Q3 2025, an estimated $51.9K.
  • Qube Research & Technologies (QRT) first reported a position in Douglas Elliman in Q4 2021 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s Douglas Elliman position peaked at $942K in Q2 2023.
  • 128 funds tracked by Wall St. Rank held Douglas Elliman as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.